Blood Plasma Product

The present invention relates to a spray dried plasma composition having one or more of the following characteristics: when reconstituted, largely amorphous and has no cholesterol crystals; when reconstituted, the number of large particulates is reduced; has low residual moisture; reconstitutes rapidly in under four minutes; highly stable when stored under refrigeration, at room temperature or at elevated temperatures and allows for storage for longer periods of time; when reconstituted, exhibits recovery of the most fragile of proteins, including von Willebrand's factor; when reconstituted with Sterile Water for Injection (SWFI), reconstituted plasma is at a pH that is near normal plasma pH, and does so without treatment or storage in CO2 or other pH adjustment; and when reconstituted, has reduced complement activation (C5A, C3A)..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 04. Apr. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

LIU QIYONG PETER [VerfasserIn]
SNYDER HERMAN E [VerfasserIn]
ERICKSON KYLE D [VerfasserIn]
ORDWAY EVAN P [VerfasserIn]
MERRITT WILLIAM J [VerfasserIn]
MEEHAN RICHARD [VerfasserIn]
ANDREWS ROBERT R [VerfasserIn]
STROHL CLAIR [VerfasserIn]
SOHN JIHAE [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
B01D: Separation (separating solids from solids by wet me (...)
B01J: Chemical or physical processes, e.g. catalysis or c (...)
cet
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-04-04, Last update posted on www.tib.eu: 2024-05-01, Last updated: 2024-05-10

Patentnummer:

US2024109000

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA003597849